Lobular carcinoma in situ
HY Wen, E Brogi - Surgical pathology clinics, 2018 - Elsevier
Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …
Current management of lesions associated with an increased risk of breast cancer
M Morrow, SJ Schnitt, L Norton - Nature reviews Clinical oncology, 2015 - nature.com
High-risk breast lesions, which comprise benign lesions and in situ carcinomas (lobular
carcinoma in situ and ductal carcinoma in situ), are clinically, morphologically, and …
carcinoma in situ and ductal carcinoma in situ), are clinically, morphologically, and …
[HTML][HTML] Atypical hyperplasia of the breast—risk assessment and management options
LC Hartmann, AC Degnim, RJ Santen… - … England Journal of …, 2015 - Mass Medical Soc
Atypical Hyperplasia of the Breast — Risk Assessment and Management Options | NEJM
Skip to main content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn …
Skip to main content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn …
NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy …
SE Pinder, A Shaaban, R Deb, A Desai, A Gandhi… - Clinical radiology, 2018 - Elsevier
Needle core biopsy is considered the histological diagnostic method of choice for screen-
detected breast lesions. Although the majority are definitively diagnosed as normal, benign …
detected breast lesions. Although the majority are definitively diagnosed as normal, benign …
High-risk lesions of the breast: concurrent diagnostic tools and management recommendations
F Catanzariti, D Avendano, G Cicero… - Insights into …, 2021 - Springer
Breast lesions with uncertain malignant behavior, also known as high-risk or B3 lesions, are
composed of a variety of pathologies with differing risks of associated malignancy. While …
composed of a variety of pathologies with differing risks of associated malignancy. While …
Incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective …
F Nakhlis, L Gilmore, R Gelman, I Bedrosian… - Annals of surgical …, 2016 - Springer
Background Lobular neoplasia (LN) represents a spectrum of atypical proliferative lesions,
including atypical lobular hyperplasia and lobular carcinoma-in-situ. The need for excision …
including atypical lobular hyperplasia and lobular carcinoma-in-situ. The need for excision …
Atypical ductal hyperplasia and lobular neoplasia: update and easing of guidelines
AA Lewin, CL Mercado - American Journal of …, 2020 - Am Roentgen Ray Soc
OBJECTIVE. Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), and
lobular carcinoma in situ (LCIS) are among high-risk lesions that have been previously …
lobular carcinoma in situ (LCIS) are among high-risk lesions that have been previously …
Fine-needle versus core-needle biopsy–which one to choose in preoperative assessment of focal lesions in the breasts? Literature review
E Łukasiewicz, A Ziemiecka, W Jakubowski… - Journal of …, 2017 - sciendo.com
Aim: The aim of the study was to review two techniques that can be used to verify focal
lesions in the breasts: fine-needle aspiration biopsy and core-needle biopsy. Material and …
lesions in the breasts: fine-needle aspiration biopsy and core-needle biopsy. Material and …
[HTML][HTML] High-risk and selected benign breast lesions diagnosed on core needle biopsy: Evidence for and against immediate surgical excision
A Harbhajanka, HL Gilmore, BC Calhoun - Modern Pathology, 2022 - Elsevier
The vast majority of image-detected breast abnormalities are diagnosed by percutaneous
core needle biopsy (CNB) in contemporary practice. For frankly malignant lesions …
core needle biopsy (CNB) in contemporary practice. For frankly malignant lesions …
Pleomorphic and florid lobular carcinoma in situ variants of the breast: a clinicopathologic study of 85 cases with and without invasive carcinoma from a single …
ER Shamir, YY Chen, T Chu, M Pekmezci… - The American Journal …, 2019 - journals.lww.com
The natural history and optimal treatment of pleomorphic (PLCIS) and florid (FLCIS) lobular
carcinoma in situ variants remains uncertain. We reviewed the clinicopathologic features …
carcinoma in situ variants remains uncertain. We reviewed the clinicopathologic features …